Richard G. Patton

Dr. Patton is a board-certified pathologist with more than 35 years of active practice experience. Recognizing the patient safety and financial implications of false positive blood cultures, he has long been interested in exploring opportunities to reduce contamination rates.

In 2006, Dr. Patton designed a clinical trial to test the effectiveness of Initial Specimen Diversion Technique (ISDT), an innovation that he conceived earlier in his career.

The results of the trial were significantly positive and published in the peer-reviewed Journal of Clinical Microbiology. Dr. Patton’s areas of expertise are Anatomic Pathology, Clinical Pathology, and Cytopathology with sub-specialty expertise in Laboratory Administration.

He is the chief pathologist and Medical Director of Clinical Laboratories at UW Medicine/Northwest Hospital & Medical Center, acts as the Washington State Commissioner for the College of American Pathologists Laboratory Accreditation Program, is an Associate Clinical Professor of Pathology at University of Washington, and is a published international thought leader on blood culture contamination.

Richard G. Patton is the Co-Founder & Medical Director at Magnolia Medical Technologies. With a background in Health Care, Richard G. Patton has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.